C-terminal variants of the P2X7 receptor are associated with prostate cancer progression and bone metastasis - evidence from clinical and pre-clinical data.
Haiping SongHector Manuel Arredondo CarreraAlexandria SprulesYing JiTongsong ZhangJiepei HeEleanor LawrenceAlison GartlandJian LuoNing WangPublished in: Cancer communications (London, England) (2022)